(Updated with stock prices.)

Bernard Madoff, perpetrator of the multibillion-dollar Ponzi scheme that destroyed the financial health of hundreds, even thousands, of people, received a

150-year jail sentence

on Monday morning.

Also making headlines,

Microsoft

(MSFT) - Get Report

might unload a 2007 acquisition, Razorfish,

to a French marketing company. Microsoft closed up 51 cents, or $2.18, at $23.86 on Monday.

Swiss drug company

Novartis

(NVS) - Get Report

is reportedly considering a purchase of

Elan's

(ELN)

multiple sclerosis treatment

, Tsyabri, and other operations from the Irish biotech. Novartis closed down 17 cents at $41.17 on Monday, while Elan slid 41 cents, or 5.6%, to $6.95

And in

analyst upgrade-downgrade news

, Deutsche Bank downgraded

Biogen Idec

(BIIB) - Get Report

to hold from buy, Friedman Billings Ramsey downgraded

Alcoa

(AA) - Get Report

to underperform, and Credit Suisse upgraded

KB Home

(KBH) - Get Report

to neutral from underperform.

Biogen lost $2.75, or 5.5%, on Monday to close at $47.32; Alcoa slid 32 cents, or 3%, to $10.44; and KB Home added 69 cents, or 5.1%, to $14.11.

With this in mind, we thought we'd take a look at some of the stocks in the news and see what Jim Cramer's had to say about them lately.

To read more,

visit Stockpickr.com

.

Stockpickr is a wholly owned subsidiary of TheStreet.com.